Ourania Tatsis Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ourania Tatsis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Ourania Tatsis for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 237.81 | 240 | 57,074 | 12,738 | 13 K to 12.7 K (-1.85 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 235.39 | 160 | 37,662 | 12,978 | 13.1 K to 13 K (-1.22 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 234.43 | 240 | 56,263 | 13,138 | 13.4 K to 13.1 K (-1.79 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 232.43 | 80 | 18,594 | 13,378 | 13.5 K to 13.4 K (-0.59 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 231.82 | 160 | 37,091 | 13,458 | 13.6 K to 13.5 K (-1.17 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 229.57 | 416 | 95,501 | 13,618 | 14 K to 13.6 K (-2.96 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Payment of Exercise | F | 239.23 | 1,036 | 247,842 | 14,034 | 15.1 K to 14 K (-6.87 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 155.57 | 408 | 63,473 | 3,261 | |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 187.53 | 559 | 104,829 | 6,704 | |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 242.47 | 66 | 16,003 | 16,946 | 17 K to 16.9 K (-0.39 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 240.70 | 90 | 21,663 | 17,012 | 17.1 K to 17 K (-0.53 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 239.68 | 240 | 57,523 | 17,102 | 17.3 K to 17.1 K (-1.38 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 238.77 | 571 | 136,338 | 17,342 | 17.9 K to 17.3 K (-3.19 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 155.57 | 408 | 63,473 | 17,913 | 17.5 K to 17.9 K (+2.33 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 187.53 | 559 | 104,829 | 17,505 | 16.9 K to 17.5 K (+3.30 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Grant | A | 0.00 | 6,194 | 0 | 16,946 | 10.8 K to 16.9 K (+57.61 %) |
| Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Grant | A | 0.00 | 3,500 | 0 | 10,752 | 7.3 K to 10.8 K (+48.26 %) |